ARCHIVES

In Brief: Fischinger, SAIC Win $400 Million Contract

This article is from The Cancer Letter archive.

Vol. 21 No. 09 | March 3, 1995

Download PDF Visit The Full Archive

Related Articles

Phase II Study Finds Dasatinib May Overcome ALL Resistance

May 25, 2007

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

O’Connor Is New NS President, Curtiss Is Next

May 24, 1991

Lapatinib Improves Outcome Of Advanced Breast Cancer

July 28, 2006

New Control Grant Guidelines Include Community Resources Development

August 22, 1975